156 related articles for article (PubMed ID: 35749859)
1. Earlier age of onset is associated with a pro-inflammatory state in major depressive disorder.
Anzolin AP; Feiten JG; Bristot G; Possebon GMP; Fleck MPA; Caldieraro MA; Kauer-Sant'Anna M
Psychiatry Res; 2022 Aug; 314():114601. PubMed ID: 35749859
[TBL] [Abstract][Full Text] [Related]
2. Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder.
Liu L; Yang X; Yang C; Tian Y; Li W; Xia L; Liu H
J Affect Disord; 2024 Apr; 350():110-117. PubMed ID: 38220096
[TBL] [Abstract][Full Text] [Related]
3. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
[TBL] [Abstract][Full Text] [Related]
4. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation.
Al-Hakeim HK; Al-Rammahi DA; Al-Dujaili AH
J Affect Disord; 2015 Aug; 182():106-14. PubMed ID: 25985379
[TBL] [Abstract][Full Text] [Related]
5. Difference in proinflammatory cytokines produced by monocytes between patients with major depressive disorder and healthy controls.
Zhang HX; Xu YQ; Li YY; Lu MF; Shi SX; Ji JL; Wang LW
J Affect Disord; 2018 Jul; 234():305-310. PubMed ID: 29587166
[TBL] [Abstract][Full Text] [Related]
6. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
Liu Y; Ho RC; Mak A
J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
[TBL] [Abstract][Full Text] [Related]
7. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
Zou W; Feng R; Yang Y
PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
[TBL] [Abstract][Full Text] [Related]
8. IL-4 as a potential biomarker for differentiating major depressive disorder from bipolar depression.
Lu L; Hu X; Jin X
Medicine (Baltimore); 2023 Apr; 102(15):e33439. PubMed ID: 37058046
[TBL] [Abstract][Full Text] [Related]
9. Association of interleukin-10 levels with age of onset and duration of illness in patients with major depressive disorder.
Gazal M; Jansen K; Souza LD; Oses JP; Magalhães PV; Pinheiro R; Ghisleni G; Quevedo L; Kaster MP; Kapczinski F; da Silva RA
Braz J Psychiatry; 2015; 37(4):296-302. PubMed ID: 26421934
[TBL] [Abstract][Full Text] [Related]
10. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Hannestad J; DellaGioia N; Bloch M
Neuropsychopharmacology; 2011 Nov; 36(12):2452-9. PubMed ID: 21796103
[TBL] [Abstract][Full Text] [Related]
11. Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder.
Das R; Emon MPZ; Shahriar M; Nahar Z; Islam SMA; Bhuiyan MA; Islam SN; Islam MR
Psychiatry Res; 2021 Jan; 295():113568. PubMed ID: 33199026
[TBL] [Abstract][Full Text] [Related]
12. Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.
Mao R; Zhang C; Chen J; Zhao G; Zhou R; Wang F; Xu J; Yang T; Su Y; Huang J; Wu Z; Cao L; Wang Y; Hu Y; Yuan C; Yi Z; Hong W; Wang Z; Peng D; Fang Y
J Affect Disord; 2018 Sep; 237():65-72. PubMed ID: 29778935
[TBL] [Abstract][Full Text] [Related]
13. Association between inflammatory cytokines and symptoms of major depressive disorder in adults.
Min X; Wang G; Cui Y; Meng P; Hu X; Liu S; Wang Y
Front Immunol; 2023; 14():1110775. PubMed ID: 36860860
[TBL] [Abstract][Full Text] [Related]
14. Hyper-inflammation of astrocytes in patients of major depressive disorder: Evidence from serum astrocyte-derived extracellular vesicles.
Xie XH; Lai WT; Xu SX; Di Forti M; Zhang JY; Chen MM; Yao LH; Wang P; Hao KK; Rong H
Brain Behav Immun; 2023 Mar; 109():51-62. PubMed ID: 36587855
[TBL] [Abstract][Full Text] [Related]
15. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
16. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder.
Sarmin N; Roknuzzaman ASM; Mouree TZ; Islam MR; Al Mahmud Z
Sci Rep; 2024 Jan; 14(1):1652. PubMed ID: 38238514
[TBL] [Abstract][Full Text] [Related]
18. Differences in the immune-inflammatory profiles of unipolar and bipolar depression.
Brunoni AR; Supasitthumrong T; Teixeira AL; Vieira EL; Gattaz WF; Benseñor IM; Lotufo PA; Lafer B; Berk M; Carvalho AF; Maes M
J Affect Disord; 2020 Feb; 262():8-15. PubMed ID: 31693974
[TBL] [Abstract][Full Text] [Related]
19. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.
Rethorst CD; Greer TL; Toups MS; Bernstein I; Carmody TJ; Trivedi MH
Transl Psychiatry; 2015 Aug; 5(8):e611. PubMed ID: 26241349
[TBL] [Abstract][Full Text] [Related]
20. Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression.
Debnath M; Berk M; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110343. PubMed ID: 33961966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
